Our data highlight the protective role of IL-13 in protecting from more severe CDI and the association of poor responses with a dysregulated monocyte-macrophage compartment. These results increase our understanding of type 2 immunity in CDI and may have implications for treating disease in patients.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- clostridium difficile
- peritoneal dialysis
- adipose tissue
- electronic health record
- early onset
- endothelial cells
- big data
- patient reported outcomes
- immune response
- patient reported
- drug induced
- deep learning
- artificial intelligence